MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Massive Thromboembolism, PFO, and Acute Limb Ischemia
Moderator: Mohamad Alkhouli, MDPanelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa'N, MD
TAVR: General Anesthesia or Moderate Conscious Sedation?
A report of findings from registries and large cohorts.
By Hasan Rehman, MD; Neal S. Kleiman, MD, FACC, MSCAI; and Ankur Kalra, MD, FACP, FACC, FSCAI
Large Study From Nationwide Database Suggests Invasive Therapy Is Safe and Effective to Treat NSTEMI in Patients With CKD
June 21, 2022—Indiana University (IU) School of Medicine in Indianapolis, Indiana, announced the publication of an observational study of 141,000 patients that suggests physicians should consider an early invasive strategy in treating patients with chronic kidney disease (CKD) who are experiencing a non–ST-segment elevation myocardial infarction (NSTEMI).
Perspectives in TAVR
By Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC, and Samir Kapadia, MD, FACC, FSCAI
Meeting the Challenge…
By Azeem Latib, MD
Study Compares Early Outcomes of TAVI Versus SAVR in Real-World Patients With Bicuspid Aortic Valve Stenosis
June 13, 2022—In a nationwide, multicenter, propensity score–matched cohort study using real-world data comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in bicuspid aortic valve (BAV) stenosis, Majmundar et al found a reduced risk of in-hospital mortality in the TAVI group and similar rates of 30-day and 6-month major adverse cardiovascular events (MACE) between groups.
